Skip to main content
Robert Hallowell, MD, Pulmonology, Boston, MA

RobertWilliamHallowellMD

Pulmonology Boston, MA

Critical Care Medicine, Interstitial Lung Diseases

Director, Interstitial Lung Disease Program; Director, Ambulatory Pulmonary Clinic, Massachusetts General Hospital; Assistant Professor of Medicine, Harvard Medical School

Dr. Hallowell is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Hallowell's full profile

Already have an account?

  • Office

    55 Fruit St, Bulfinch 148
    Boston, MA 02114
    Phone+1 617-726-1721

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2010 - 2013
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 2007 - 2010
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 2007

Certifications & Licensure

  • MA State Medical License
    MA State Medical License Active through 2025
  • MA State Medical License
    MA State Medical License 2014 - 2025
  • NH State Medical License
    NH State Medical License 2024 - 2024
  • ME State Medical License
    ME State Medical License 2020 - 2021
  • MD State Medical License
    MD State Medical License 2010 - 2014
  • American Board of Internal Medicine Critical Care Medicine
  • American Board of Internal Medicine Pulmonary Disease

Publications & Presentations

PubMed

Journal Articles

  • Interstitial lung disease in patients with rheumatoid arthritis: spontaneous and drug-induced.  
    R.W Hallowell and M.R. Horton, Drugs, 3/1/2014
  • Pulmonary delivery of docosahexaenoic acid mitigates bleomycin-induced pulmonary fibrosis.  
    Zhao H, Chan-Li Y, Collins SL, Zhang Y, Hallowell RW, Mitzner W, Horton MR, BMC Pulmonary Medicine, 1/1/2014
  • Hyaluronan fragments induce IFNβ via a novel TLR4-TRIF-TBK1-IRF3-dependent pathway.  
    Black KE, Collins SL, Hagan RS, Hamblin MJ, Chan-Li Y, Hallowell RW, Powell JD, Horton MR, J Inflamm (Lond), 5/1/2013
  • Join now to see all

Press Mentions

  • BIDMC’s Research & Health News Digest – COVID-19 Special Edition
    BIDMC’s Research & Health News Digest – COVID-19 Special EditionMay 10th, 2020